Andrew Bascand: Investing in new technology
Listen now
Description
Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors.
Listen in for your chance to get ahead of the markets.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
More Episodes
Published 05/20/24
As money has moved into the digital space, physical cash has become less prevalent.
Only 57.2 percent of kiwis used cash for everyday purposes in 2023, down from 95.8 percent in 2019. Those using cash tend to be among more vulnerable groups, including the young, elderly and disabled, and are...
Published 05/12/24
Published 05/12/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
